EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY-NC-ND 4.0

Comparison of enriched charge variants from different anti‐ CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post‐translational modification

Jennifer B Nguyen iD, Sophia Liu, Dylan A Howie, Zachary R Oberholtzer, Eric T Ong, Ramya Rao, Jethro E Prinston, Igor Dikiy, Jikang Wu, Zhijie Wu, Yimeng Zhao, Meinuo Li and 9 more

Protein Science · 2025

DOI: 10.1002/pro.70079 ↗

At a glance

Vergleichsstudie in Protein Science, 2025. Written by Jennifer B Nguyen and 20 co-authors. Institution: Protein Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. Major MEDLINE topics: Antibodies, Bispecific, Protein Processing, Post-Translational, CD3 Complex. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Charge heterogeneity is an important quality attribute of therapeutic antibodies, and a detailed understanding of charge heterogeneity arising from post‐translational modifications (PTMs) is required by regulatory agencies during drug development. Among antibody therapeutics, the bispecific antibody with two distinct Fab domains targeting distinct antigens provides additional complexity to the charge profile. In this study, charge variant species were enriched from three bispecific antibodies (bsAbs) each containing one anti‐CD3 binding arm designed with differential affinity to CD3. The charge heterogeneity corresponding to each anti‐CD3 arm within each enriched fraction was evaluated using a domain‐specific, digestion‐assisted imaged capillary isoelectric focusing (icIEF) method known as DiCE. Through fractionation, we observed that the anti‐CD3 arm of each bispecific antibody exhibited different distributions of acidic variants, even when the anti‐CD3 arms were identical based on primary sequence. Reduced peptide mapping was performed on specific fractions to identify unique site‐specific PTMs that were uncovered or enriched through fractionation. In each case, the bispecific arm that was most susceptible to PTMs exhibited a more basic isoelectric point. Conformational stability analysis of each bispecific antibody using differential scanning calorimetry suggested that the more basic Fab arm tended to be correlated with a lower melting temperature, although it is unclear the extent to which PTMs on the basic arm may contribute to reduced conformational stability. Overall, these results provide additional evidence that each of the two arms of a bispecific antibody may exhibit differential susceptibility to post‐translational modification and that this susceptibility is likely correlated with subtle differences in overall bispecific antibody structure, which is influenced by electrostatic properties inherent to the primary sequence. Future studies to obtain high‐resolution structures of full‐length bispecific antibodies by crystallography or cryo‐electron microscopy may help to elucidate the driving force for susceptibility to PTMs in bispecific antibodies.

Subjects

MeSH terms (MEDLINE)

Antibodies, BispecificProtein Processing, Post-TranslationalCD3 ComplexHumans

Author keywords

CD3analytical characterizationbispecific antibodiesimaged capillary isoelectric focusingpost‐translational modification

Substances

Antibodies, BispecificCD3 Complex

Authors and institutions

  • Protein Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
  • Therapeutic Proteins, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

ORCID profiles: Jennifer B Nguyen

Cite

APA

Nguyen, J. B., Liu, S., Howie, D. A., Oberholtzer, Z. R., Ong, E. T., Rao, R., Prinston, J. E., Dikiy, I., Wu, J., Wu, Z., Zhao, Y., Li, M., Molden, R., Molina, G., Provoncha, K., Sandu, C., Qiu, H., Li, N., Matousek, W., …, & Pyles, E. A. (2025). Comparison of enriched charge variants from different anti‐ CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post‐translational modification. Protein Science. https://doi.org/10.1002/pro.70079

Vancouver

Nguyen JB, Liu S, Howie DA, Oberholtzer ZR, Ong ET, Rao R, et al. Comparison of enriched charge variants from different anti‐ CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post‐translational modification. Protein Science. 2025. doi:10.1002/pro.70079

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Jennifer B and Liu, Sophia and Howie, Dylan A and Oberholtzer, Zachary R and Ong, Eric T and Rao, Ramya and Prinston, Jethro E and Dikiy, Igor and Wu, Jikang and Wu, Zhijie and Zhao, Yimeng and Li, Meinuo and Molden, Rosalynn and Molina, Guido and Provoncha, Kathleen and Sandu, Cristinel and Qiu, Haibo and Li, Ning and Matousek, William and Rosconi, Michael P and Pyles, Erica A},
  title = {Comparison of enriched charge variants from different anti‐ CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post‐translational modification},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70079}
}
Start for free →